4/A

PRIMARY DOCUMENT

Company: LIGAND PHARMACEUTICALS INC
Filed: June 16, 2004
Period of Report: May 26, 2004
Accession Number: 0001019687-04-001354

View Document ↗ View on SEC.gov ↗